Familiaire hypercholesterolemie: Waarom opsporing en behande ling bij elkaar horen

Jeanine E Roeters Van Lennep; Frank L J Visseren; Petr E. Jira

Familiaire hypercholesterolemie: Waarom opsporing en behande ling bij elkaar horen

Translated title of the contribution: Familial hypercholesterolemia: Why screening, counselling and treatment should be integrated

Jeanine E Roeters Van Lennep^*, Frank L J Visseren, Petr E. Jira

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Familial hypercholesterolemia (FH) is a monogenic autosomal dominant disorder. FH is the most common hereditary cause of raised serum cholesterol levels and is associated with an increased risk of premature cardiovascular disease (CVD). This disorder is known to have a genetic cause, and effective drug therapies exist for patients with FH. Successful cascade screening, within the framework of a national screening programme, gave the Netherlands an international role as model and pioneer as far as FH detection is concerned. With the ending of this screening programme as of 1 January 2014 the care for FH patients, including screening and counselling has had to be incorporated within the basic Dutch healthcare insurance system. It is essential that detection of FH should continue in as efficient and costeffective a manner as possible. Our proposal is that this detection should be performed and coordinated by those treating patients with FH so that FH screening, counselling and treatment are integrated.

Translated title of the contribution	Familial hypercholesterolemia: Why screening, counselling and treatment should be integrated
Original language	Dutch
Article number	A8875
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	159
Issue number	27
Publication status	Published - 1 Jan 2015

Cite this

@article{c2496538d5d9427999227a5ef22a50d7,

title = "Familiaire hypercholesterolemie: Waarom opsporing en behande ling bij elkaar horen",

abstract = "Familial hypercholesterolemia (FH) is a monogenic autosomal dominant disorder. FH is the most common hereditary cause of raised serum cholesterol levels and is associated with an increased risk of premature cardiovascular disease (CVD). This disorder is known to have a genetic cause, and effective drug therapies exist for patients with FH. Successful cascade screening, within the framework of a national screening programme, gave the Netherlands an international role as model and pioneer as far as FH detection is concerned. With the ending of this screening programme as of 1 January 2014 the care for FH patients, including screening and counselling has had to be incorporated within the basic Dutch healthcare insurance system. It is essential that detection of FH should continue in as efficient and costeffective a manner as possible. Our proposal is that this detection should be performed and coordinated by those treating patients with FH so that FH screening, counselling and treatment are integrated.",

author = "{Van Lennep}, {Jeanine E Roeters} and Visseren, {Frank L J} and Jira, {Petr E.}",

year = "2015",

month = jan,

day = "1",

language = "Dutch",

volume = "159",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

number = "27",

}

TY - JOUR

T1 - Familiaire hypercholesterolemie

T2 - Waarom opsporing en behande ling bij elkaar horen

AU - Van Lennep, Jeanine E Roeters

AU - Visseren, Frank L J

AU - Jira, Petr E.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Familial hypercholesterolemia (FH) is a monogenic autosomal dominant disorder. FH is the most common hereditary cause of raised serum cholesterol levels and is associated with an increased risk of premature cardiovascular disease (CVD). This disorder is known to have a genetic cause, and effective drug therapies exist for patients with FH. Successful cascade screening, within the framework of a national screening programme, gave the Netherlands an international role as model and pioneer as far as FH detection is concerned. With the ending of this screening programme as of 1 January 2014 the care for FH patients, including screening and counselling has had to be incorporated within the basic Dutch healthcare insurance system. It is essential that detection of FH should continue in as efficient and costeffective a manner as possible. Our proposal is that this detection should be performed and coordinated by those treating patients with FH so that FH screening, counselling and treatment are integrated.

AB - Familial hypercholesterolemia (FH) is a monogenic autosomal dominant disorder. FH is the most common hereditary cause of raised serum cholesterol levels and is associated with an increased risk of premature cardiovascular disease (CVD). This disorder is known to have a genetic cause, and effective drug therapies exist for patients with FH. Successful cascade screening, within the framework of a national screening programme, gave the Netherlands an international role as model and pioneer as far as FH detection is concerned. With the ending of this screening programme as of 1 January 2014 the care for FH patients, including screening and counselling has had to be incorporated within the basic Dutch healthcare insurance system. It is essential that detection of FH should continue in as efficient and costeffective a manner as possible. Our proposal is that this detection should be performed and coordinated by those treating patients with FH so that FH screening, counselling and treatment are integrated.

UR - http://www.scopus.com/inward/record.url?scp=84936818159&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84936818159

SN - 0028-2162

VL - 159

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 27

M1 - A8875

ER -

Familiaire hypercholesterolemie: Waarom opsporing en behande ling bij elkaar horen

Abstract

Other files and links

Fingerprint

Cite this